Low libido is the most frequently reported sexual dysfunction. This is an important and complex problem with multiple causes. At present the interpretation of data on this topic remains a challenge, as the subject population is diverse and various tools are used in assessment. Coupled with this, several definitions are in use with differing emphasis on distress resulting from this state. Developments in the understanding of psychopharmacology are shedding light on the pathways involved in normal sexual response and these are being utilized in the development of treatments. This article reviews the current definitions, aetiology and treatment options and explores the recent developments in low libido in women.
NazarethI, BoyntonP, KingM. Problems with sexual function in peopleattending London general practitioners: cross sectional study. BMJ2003;327:423
3.
MercerCH, FentonKA, JohnsonAM, Sexual function problems and help seeking behaviour in Britian: national probability sample survey. BMJ2003;327:426–7
4.
GottM, GalenaE, HinchliffS, ElfordH. ‘Opening a can of worms’: GP and practice nurse barriers to talking about sexual health in primary care. Fam Pract2004;21:528–36
5.
EmersonCR, GoldmeierD, GreenP. Assessing training in sexual dysfunction for genitourinary medicine registrars. Int J STD AIDS2009;20:745–7
6.
MastersWH, JohnstonVE. Human Sexual Response. Boston, MA: Little, Brown & Co, 1966
7.
KaplanHS. Hypoactive sexual drive. J Sex Marital Ther1979;3:3–9
8.
BassonR. Human sex-response cycles. J Sex Marital Ther2000;27:33–43
9.
GoldmeierD. ‘Responsive’ sexual desire in women – managing the normal?Sex Rel Ther2001;16:381–7
10.
SandM, FisherMA. Women's endorsement of models of female sexual response: the nurses' sexuality study. J Sex Med2007;4:708–19
11.
American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. 4th edn, text revision [DSM-IV-TR]. Washington, DC: The Association, 2000
12.
World Health Organization. ICD-10: International statistical classification of diseases and related health problems, 10th revision. See http://www.who.int/classifications/apps/icd/icd10online/ (last checked December 2009)
13.
BassonR, BermanJ, BurnettA, Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol2000;163:888–93
14.
15.
HartmannU, HeiserK, Ruffer-HesseC, KlothG. Female sexual desire disorders: subtypes, classification, personality factors and new directions for treatment. World J Urol2002;20:79–88
16.
MitchellKR, MercerCH, WellingsK, JohnstonAM. Prevalence of low sexual desire among women in Britain: associated factors. J Sex Med2009;6:2434–44
17.
BancroftJ, LoftusJ, LongJS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav2003;32:193–208
18.
RichtersJ, GrulichAE, de VisserRO, SmithAMA, RisselCE. Sex in Australia: sexual difficulties in a representative sample of adults. Aust N Z J Public Health2003;27:164–70
19.
LaumannEO, PaikA, RosenRC. Sexual dysfunction in the United States: prevalence and predictors. JAMA1999;281:537–44
20.
HayesRD, BennettCM, FairleyCK, DennersteinL. What can prevalence studies tell us about female sexual difficulty and dysfunction?J Sex Med2006;3:589–95
21.
WestSL, D'AloisioAA, AgansRP, KalsbeekWD, BorisovNN, ThorpJM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med2008;168:1441–9
22.
HayesRD, DennersteinL, BennettCM, KoochakiPE, LeiblumSR, GraziottinA. Relationship between hypoactive sexual desire disorder and aging. Fertil Steril2007;87:107–12
23.
HayesRD. Assessing female sexual dysfunction in epidemiological studies: why it is necessary to measure both low sexual function and sexually-related distress?Sexual health2008;5:215–8
24.
ClaytonAH, PradkoJF, CroftHA, Prevalence of sexual dysfunctions among new antidepressants. J Clin Psychiatry2002;63:357–66
25.
WarnockJJ. Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment. CNS Drugs2002;16:745–53
26.
BrownAD, BlaggJ, ReynoldsDS. Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today2007;12:757–66
27.
FrankJR, MistrettaP, WillJ. Diagnosis and treatment of female sexual disfunction. Am Fam Physician2008;77:635–42
28.
Schreiner-EngelP, SchiaviRC, WhiteD, GhizzaniA. Low sexual desire in women: the role of reproductive hormones. Horm Behav1989;23:221–34
29.
StuartFM, HammondDC, PettMA. Inhibited sexual desire in women. Arch Sex Behav1987;16:91–106
30.
DavisSR, MoreauM, KrollR, Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med2008;359:2005–17
31.
JohnsonSD, PhelpsDL, CottlerLB. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch Sex Behav2004;33:55–63
32.
LaumannE, GagnonJ, MichaelR, MichaelsS. The Social Organisation of Sexuality. Sexual Practices in the United States. Chicago: University of Chicago Press, 1994
33.
LeiblumSR, KoochakiP, RodenburgCA, BartonIP, RosenRC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause2006;13:46–56
34.
GraziottinA. Prevalence and evaluation of sexual health problems-HSDD in Europe. J Sex Med2007;4:211–9
35.
DerogatisLR, RosenR, LeiblumS, BurnettA, HeimanJ. The female sexual distress scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther2002;28:317–30
36.
DerogatisL, ClaytonA, Lewis-D'AgostinoD, WunderlichG, FuY. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med2008;5:357–64
37.
RosenR, BrownC, HeimanJ, The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther2000;26:191–208
38.
ClaytonAH, SegravesRT, LeiblumS, Reliability and validity of the sexual interest and desire inventory-female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder. J Sex Marital Ther2006;32:115–35
39.
RustJ, DerogatisL, RodenburgC, KoochakiP, SchmittS, GolombokS. Development and validation of a new screening tool for hypoactive sexual desire disorder: the Brief Profile of Female Sexual Function (B-PFSF). Gynecol Endocrinol2007;23:638–44
40.
DerogatisLR, AllgoodA, RosenRC, LeiblumS, ZipfelL, GuoCY. Development and evaluation of the Women's Sexual Interest Diagnostic Interview (WSID): a structured interview to diagnose Hypoactive Sexual Desire Disorder (HSDD) in standardized patients. J Sex Med2008;5:2827–41
41.
BraunsteinGD, SundwallDA, KratzM. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med2005;165:1582–9
42.
DavisSR, MoreauM, KrollR, Testosterone for low libido in postmenopausal women not taking estrogen. New Engl J Med2008;359:2005–7
43.
LaanE, Van LunsenR, EveraerdW. The effect of tibilone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric2001;1:28–41
44.
SegravesRT, WoodardT. Female hypoactive desire disorder: history and current status. J Sex Med2006;3:408–18
45.
SegravesRT, ClaytonA, CroftH, WolfA, WarnockJ. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol2004;4:339–42
46.
BermanJ, BermanL, TolerS, GillJ, HaughieS. Safety and efficacy of Sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol2003;170:2333–8
47.
WylieK, MalikF. Review of drug treatment for female sexual dysfunction. Int J STD AIDS2009;20:671–4
48.
NappiR, DeanJ, Van LunsenR, HerbertA, KimuraT, PykeR. Efficacy of flibanserin as a potential treatment for hypoactive sexual desire disorder in European premenopausal women: results from the ORCHID trial. J Sex Med2009;6:409 (abstract)
